RELATION BETWEEN BILIRUBIN LEVELS IN SKIN AND BLOOD BILIRUBIN LEVELS IN PRETERM INFANTS ( BORN AT GESTATIONAL AGE FROM 28 WEEKS TO 35 WEEKS )
Not Applicable
- Conditions
- Health Condition 1: P84- Other problems with newborn
- Registration Number
- CTRI/2023/02/049478
- Lead Sponsor
- ot applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Preterm infants more than 28 weeks of gestation and less than 35 weeks of gestation. And showing signs of clinical jaundice and/or elevated trans-cutaneous bilirubin (2 mg below phototherapy threshold and above) or elevated serum bilirubin ( at or above phototherapy threshold ) warranting phototherapy admitted in NICU, department of paediatrics, Kasturba Hospital, Manipal
Exclusion Criteria
• <28 and >35 weeks of gestation
•Conditions that could interfere with TCB measurements such as
Congenital malformations
Hydrops fetalis
Diffuse cutaneous conditions
Purpura
Neonates requiring exchange transfusion
Critically ill preterms
And age more than 21 days of life.
•Bilirubin levels not warranting phototherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between transcutaneous bilirubin and total serum bilirubin levels in preterm infants before, during and/or after phototherapyTimepoint: From the time preterm with clinical jaundice, elevated serum or Trans-cutaneous bilirubin levels noted, warranting phototherapy till stopping phototherapy and rechecking for rebound bilirubin levels. Assessment done at the end of the study sample collection 1 year 7 months.
- Secondary Outcome Measures
Name Time Method Corelation of TSB and TCB among different gestational ages and Corelation with the sites used for TCBTimepoint: From the time preterm with clinical jaundice, elevated serum or Trans-cutaneous bilirubin levels noted, warranting phototherapy till stopping phototherapy and rechecking for rebound bilirubin levels. Assessment done at the end of study sample collection 1 year 7 months